Steven Sigalove
Plastic and Reconstructive Surgery · Glen Ellyn, ILNPI 1447228754
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Tepha Inc at 27.2% of the total. Reporting peaked in 2019 at $70,660 and has fallen 92.5% since, to $5,325 in 2025. Among plastic and reconstructive surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 377 payments — averaging $577.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tepha Inc$59K
- Davol Inc.$55K
- AbbVie$49K
- KCI USA, Inc.$25K
- Sientra, Inc.$18K
- Motiva USA, LLC$8K
- plus $4K from 15 others
What the payments were for
- Consulting fees$122,72056%
- Speaking & faculty fees$72,86333%
- Travel & lodging$4,8202%
- Food & beverage$16,9008%
- Education$1950%
- Gifts$1120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tepha Inc | 115 | $59,126 |
| Davol Inc. | 73 | $55,115 |
| AbbVie(2 entities) | 56 | $48,544 |
| KCI USA, Inc. | 13 | $24,930 |
| Sientra, Inc. | 41 | $18,132 |
| Motiva USA, LLC | 33 | $8,248 |
| TELA Bio, Inc. | 6 | $1,359 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $700 |
| Mentor Worldwide LLC | 9 | $369 |
| Galderma Laboratories, L.p. | 12 | $222 |
| Dilon Technologies, Inc. | 3 | $168 |
| RTI Surgical, Inc | 1 | $146 |
| Johnson & Johnson(2 entities) | 2 | $139 |
| Revance Therapeutics, Inc. | 4 | $132 |
| Stryker | 1 | $121 |
| Integra Lifesciences Corporation | 2 | $47 |
| Merz North America, Inc. | 1 | $28 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $24 |
| Acelrx Pharmaceuticals, Inc. | 1 | $22 |
| Innovation Technologies Inc | 1 | $21 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GalaFLEX$57,688
- ALLODERM$47,017
- STRATTICE$23,940
- PREVENA$17,529
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$17,164
- NATRELLE$14,414
- Motiva Implant Matrix$7,163
- VAC VERAFLO$6,889
- V.A.C. VERAFLO$3,300
- Phasix Mesh$2,455
- OviTex 2S$1,000
- PREVENA RESTOR BELLAFORM$550
- ADAPTIC$431
- VAC ULTA$431
- KERRACONTACT AG (US)$191
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$170
- Avitene Ultrafoam$158
- CORTIVA ALLOGRAFT DERMIS$146
- BOTOX$141
- Motiva SmoothSilk Round Breast Implant$139
How this compares
$217,610 in reported general payments places this provider in the 95th percentile of 126 plastic and reconstructive surgery providers in Illinois.
See all plastic and reconstructive surgery providers in Illinois →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 20 | $110 |
| Ondansetron Hcl | 15 | $29 |
| Ibuprofen | 11 | $15 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Glen Ellyn
- John KimChicago$7.3M
- Mark SiscoNorthbrook$309K
- Matthew EndaraJoliet$204K
- Brian MaileySpringfield$182K
- Julius FewChicago$148K
- Eleanor BucholzMaywood$63K
- Gregory DumanianChicago$50K
- Daniel LiuZion$47K
- Laurie CasasGlenview$36K
- Alan ChenJoliet$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.